These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

757 related items for PubMed ID: 24103663

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intravenous tissue plasminogen activator for patients with minor ischemic stroke.
    Huisa BN, Raman R, Neil W, Ernstrom K, Hemmen TM.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):732-6. PubMed ID: 21531576
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World.
    Suzuki J, Nakai N, Kondo N, Tsuji H, Inagaki R, Furukawa S, Iwata M, Nishida S, Ito Y.
    Cerebrovasc Dis; 2018 Nov; 46(3-4):184-192. PubMed ID: 30384371
    [Abstract] [Full Text] [Related]

  • 6. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [Abstract] [Full Text] [Related]

  • 7. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB, Barazangi N, Chen C, Wong C, Grosvenor D, Rose J, Bedenk A, Morrow M, McDermott D, Hove JD, Tong DC.
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [Abstract] [Full Text] [Related]

  • 8. A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.
    Adeoye O, Knight WA, Khoury J, Schmit PA, Sucharew H, Broderick JP, Pancioli AM, CLEAR-ER Investigators.
    J Stroke Cerebrovasc Dis; 2014 May; 23(5):e313-5. PubMed ID: 24534128
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characteristics and Outcomes of Patients who Refuse Intravenous Thrombolysis for Acute Ischemic Stroke - The San Diego Experience.
    von Kleist T, Meyer D, Rapp K, Meyer BC, Modir R.
    J Stroke Cerebrovasc Dis; 2020 Nov; 29(11):105137. PubMed ID: 33066942
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial.
    Pancioli AM, Adeoye O, Schmit PA, Khoury J, Levine SR, Tomsick TA, Sucharew H, Brooks CE, Crocco TJ, Gutmann L, Hemmen TM, Kasner SE, Kleindorfer D, Knight WA, Martini S, McKinney JS, Meurer WJ, Meyer BC, Schneider A, Scott PA, Starkman S, Warach S, Broderick JP, CLEAR-ER Investigators.
    Stroke; 2013 Sep; 44(9):2381-7. PubMed ID: 23887841
    [Abstract] [Full Text] [Related]

  • 13. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
    Tong X, George MG, Yang Q, Gillespie C.
    Int J Stroke; 2014 Aug; 9(6):728-34. PubMed ID: 24024962
    [Abstract] [Full Text] [Related]

  • 14. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
    Nagaraja N, Tasneem N, Shaban A, Dandapat S, Ahmed U, Policeni B, Olalde H, Shim H, Samaniego EA, Pieper C, Ortega-Gutierrez S, Leira EC, Adams HP.
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
    [Abstract] [Full Text] [Related]

  • 15. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
    Majidi S, Leon Guerrero CR, Burger KM, Sigounas D, Olan WJ, Qureshi AI.
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
    [Abstract] [Full Text] [Related]

  • 16. Does symptom onset to primary stroke center time goals affect stroke outcome?
    Chee B, Raman R, Ernstrom K, Guzik AK, Hemmen TM, Rapp KS, Meyer BC, Meyer DM.
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(5):993-1000. PubMed ID: 24103670
    [Abstract] [Full Text] [Related]

  • 17. Even Faster Door-to-Alteplase Times and Associated Outcomes in Acute Ischemic Stroke.
    Jung S, Rosini JM, Nomura JT, Caplan RJ, Raser-Schramm J.
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104329. PubMed ID: 31607439
    [Abstract] [Full Text] [Related]

  • 18. A model to prevent fibrinolysis in patients with stroke mimics.
    Chang J, Teleb M, Yang JP, Alderazi YJ, Chapple K, Frey JL, Restrepo L.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):839-43. PubMed ID: 21640609
    [Abstract] [Full Text] [Related]

  • 19. Safety and Efficacy of Intravenous Thrombolytic Therapy in Patients With Acute Posterior Circulation Stroke: A Single-Center Study.
    Zhu X, Wang N, Lin H, Zhang P, Chen L, Zhang M, Deng B, Wu T.
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104537. PubMed ID: 31806454
    [Abstract] [Full Text] [Related]

  • 20. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
    Momosaki R, Yasunaga H, Kakuda W, Matsui H, Fushimi K, Abo M.
    Cerebrovasc Dis; 2016 Feb; 42(1-2):41-8. PubMed ID: 26986718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.